BUTICAPS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Buticaps, and when can generic versions of Buticaps launch?
Buticaps is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in BUTICAPS is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for BUTICAPS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 3,688 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUTICAPS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BUTICAPS
US Patents and Regulatory Information for BUTICAPS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Medpointe Pharm Hlc | BUTICAPS | butabarbital sodium | CAPSULE;ORAL | 085381-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |